As mentioned for CS, cabergoline is associated with a reduction in both fasting blood glucose and HbA1c (146)
Investigations purport that their interaction may provide a broader understanding of metabolic regulation, tissue maintenance, and cellular signaling networks
Medical supervision is critical for safe and effective treatment
Advertising or distributing prescription-only or unlicensed medicines through social media competitions may breach medicines regulations, and products obtained through hidden-market sellers carry serious risks, as they are not subject to safety checks, quality controls or medical oversight
Peak outcomes emerge through strategic treatment schedules spanning 1-3 sessions weekly over 4-8 weeks 11
Notably, semaglutide is not recommended for patients with severe gastrointestinal disease, such as severe gastroparesis, per FDA labeling